Evidence map›Paper›PMID 37415712›Full record

ArticleFrontiers in public health2023

Social robotics to support older people with dementia: a study protocol with Paro seal robot in an Italian Alzheimer's day center.

Roberta Bevilacqua, Elvira Maranesi, Elisa Felici, Arianna Margaritini, Giulio Amabili, Federico Barbarossa, Anna Rita Bonfigli, Giuseppe Pelliccioni, Lucia Paciaroni

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05626205 (PARO), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05626205 naunknown statusnot on this map

PARO: Psycho-social Intervention With Paro Robotic Seal Focused on Patients With Dementia

TypeinterventionalSponsorIstituto Nazionale di Ricovero e Cura per AnzianiRan2022 to 2024Enrolled20ConditionsAlzheimer Disease, Older AdultsArmsPARO robot
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Roberta BevilacquaScientific Direction, IRCCS INRCA, Ancona, Italy.
Elvira MaranesiScientific Direction, IRCCS INRCA, Ancona, Italy.
Elisa FeliciScientific Direction, IRCCS INRCA, Ancona, Italy.
Arianna MargaritiniScientific Direction, IRCCS INRCA, Ancona, Italy.
Giulio AmabiliScientific Direction, IRCCS INRCA, Ancona, Italy.
Federico BarbarossaScientific Direction, IRCCS INRCA, Ancona, Italy.
Anna Rita BonfigliScientific Direction, IRCCS INRCA, Ancona, Italy.
Giuseppe PelliccioniNeurology Unit, IRCCS INRCA, Ancona, Italy.
Lucia PaciaroniNeurology Unit, IRCCS INRCA, Ancona, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Nazionale di Riposo e Cura per Anziani · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The aging of the population and the high incidence of those over 80 lead to an inevitable increase in chronic degenerative diseases, such as dementia, resulting in increased morbidity and disability. Treatment of people with dementia involves both pharmacological and non-pharmacological interventions. In particular, robot-assisted therapy is a potentially useful treatment for dementia as it has the advantage of improving mood, encouraging social interaction and communication. The overall objective of the study is to evaluate the improvement in patient-perceived quality of life following the use of the Paro robot integrated with usual care in the older people with dementia. Methods and analysis: For this study, 20 patients with dementia are recruited and divided into Experimental Group (EG) and Control Group (CG). Twenty-four session of intervention are conducted, divided into 2 sessions per week, for 12 weeks. The therapy sessions last 20 min. The Experimental Group will receive a social robotic intervention with Paro combined with usual care; the Control Group will receive only the traditional therapy, consisting of cognitive stimulation (reality orientation therapy, cognitive training) and occupational activities (painting workshops, cooking workshops, garden therapy, music therapy, etc.). Paro is a seal-shaped robot designed to have a calming effect and elicit emotional responses in patients in hospitals, nursing homes, and retirement homes. Assessment will be performed at the baseline, at the end of intervention and 3 months after the end of intervention. During these phases, several scales will be administered to the patients, such as Quality of Life-Alzheimer's Disease, Addenbrooke's Cognitive Examination, the Rating Anxiety In Dementia scale and the Cornell Scale for Depression in Dementia, Quebec User Evaluation of Satisfaction, Neuropsychiatric Inventory, the Technology Acceptance Model. Discussions: The final goals of the present study are to evaluate the improvement in patient-perceived quality of life following the use of the Paro robot integrated with usual care in the older people with dementia. Ethics and dissemination: The study was approved by the Ethic Committee of the Istituto Nazionale Ricovero e Cura Anziani, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS INRCA) during the session of 12 April 2022. It was recorded in ClinicalTrials.gov on 23 November 2022 on the number NCT05626205. The study findings will be used for publication in peer-reviewed scientific journals and presentations in scientific meetings.

Indexed as

Alzheimer DiseaseDementiaRoboticsAgedHumansNursing HomesQuality of LifeRandomized Controlled Trials as TopicAlzheimer’s diseasedementiaolder peoplepsycho-social interventionsocial roboticsstudy protocoltechnology acceptability

Identifiers

PMID37415712
PMCPMC10321520
OpenAlexW4381511208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.